Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation factor VIII: structure and stability.

Wei Wang1, Y John Wang, Drew N Kelner

  • 1Analytics & Formulation, Biotechnology Division, Bayer Healthcare, 800 Dwight Way, Berkeley, CA 94701, USA. wei.wang@bayer.com

International Journal of Pharmaceutics
|June 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of different approaches for evaluation of the detection and quantitation limits of a purity method: a case study using a capillary isoelectrofocusing method for a monoclonal antibody.

Analytical biochemistry·2008
Same author

Human IgG2 antibodies display disulfide-mediated structural isoforms.

The Journal of biological chemistry·2008
Same author

Permeation of particle through a four-helix-bundle model channel.

The Journal of chemical physics·2005
Same author

Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys.

Vaccine·2005
Same author

Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
Same author

Towards automatic clustering of protein sequences.

Proceedings. IEEE Computer Society Bioinformatics Conference·2005
Same journal

Preventing tablet defects through vacuum-assisted deaeration of a powder bed.

International journal of pharmaceutics·2026
Same journal

Approaches for enhancing bioavailability of macromolecular drugs.

International journal of pharmaceutics·2026
Same journal

Characteristics of asymmetric microcrystalline solidification pellets and a better prediction for bioequiavailability based on solubility-permeability theory.

International journal of pharmaceutics·2026
Same journal

A CFPD-FSI analysis of the impact of nasal hairs on airflow patterns, nasal resistance, and particle filtration in a realistic human nasal airway.

International journal of pharmaceutics·2026
Same journal

Transient hydrate formation during disintegration of film-coated pharmaceutical tablets.

International journal of pharmaceutics·2026
Same journal

Erratum to "In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolution" [Int. J. Pharm. 699 (2026) 126952].

International journal of pharmaceutics·2026
See all related articles

This review covers recent research on Factor VIII (FVIII), a complex blood protein crucial for coagulation. Understanding FVIII

Area of Science:

  • Biochemistry
  • Hematology
  • Protein Science

Background:

  • Factor VIII (FVIII) is a critical blood coagulation factor.
  • FVIII is recognized as one of the most complex proteins.
  • Hemophilia treatment relies on effective FVIII products.

Purpose of the Study:

  • To review recent investigations on Factor VIII (FVIII).
  • To focus on the structure, activity, and stability of FVIII.
  • To aid in developing improved FVIII products for hemophilia patients.

Main Methods:

  • Literature review of recent scientific investigations.
  • Analysis of studies focusing on FVIII structure.
  • Examination of research on FVIII activity and stability.

Related Experiment Videos

Main Results:

  • Recent studies provide insights into FVIII's complex structure.
  • New data clarifies FVIII's role in blood coagulation.
  • Investigations highlight key factors influencing FVIII stability.

Conclusions:

  • Enhanced understanding of FVIII structure and activity is crucial.
  • Improving FVIII stability is key for developing better hemophilia treatments.
  • Further research can lead to improved quality of life for hemophilia patients.